Patients should contact their healthcare provider if they experience persistent pain, signs of infection (warmth, increasing redness, pus), or allergic reactions
As Ozempic and other GLP-1 weight-loss medications skyrocket in popularity, one unflattering side effect is earning quite a bit of attention: Ozempic face, the gaunt, prematurely aged look some patients develop after shedding pounds at record speed
In 2023 and 2024 , respectively, Ozempic and Wegovy were also approved to reduce the risk of major cardiovascular problems (e.g
The study, published Wednesday in The BMJ , a globally respected peer-reviewed British medical journal, followed patients for an average of 2.7 years and found that the increased risk was concentrated in non-scarring alopeciaa type of hair loss that does not permanently destroy the follicles
Meanwhile, individuals who took a high-potency GLP-1 drug approved for obesity such as semaglutide (Wegovy ), which is now more commonly used to treat the condition had greater persistence at 14% three years after initiating therapy
The "insufficient documentation" category is the most frustrating because it's subjective